Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imatinib mesylate in cutaneous melanoma.
Redondo P, Lloret P, Andreu EJ, Inoges S. Redondo P, et al. Among authors: inoges s. J Invest Dermatol. 2004 Dec;123(6):1208-9. doi: 10.1111/j.0022-202X.2004.23496.x. J Invest Dermatol. 2004. PMID: 15610538 Free article. No abstract available.
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
González I, Andreu EJ, Panizo A, Inogés S, Fontalba A, Fernández-Luna JL, Gaboli M, Sierrasesúmaga L, Martín-Algarra S, Pardo J, Prósper F, de Alava E. González I, et al. Among authors: inoges s. Clin Cancer Res. 2004 Jan 15;10(2):751-61. doi: 10.1158/1078-0432.ccr-0778-03. Clin Cancer Res. 2004. PMID: 14760098 Free article.
Dendritic cell vaccination in glioblastoma after fluorescence-guided resection.
Valle RD, de Cerio AL, Inoges S, Tejada S, Pastor F, Villanueva H, Gallego J, Espinos J, Aristu J, Idoate MA, Andreu E, Bendandi M. Valle RD, et al. Among authors: inoges s. World J Clin Oncol. 2012 Nov 10;3(11):142-9. doi: 10.5306/wjco.v3.i11.142. World J Clin Oncol. 2012. PMID: 23293753 Free PMC article.
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
Inogés S, Tejada S, de Cerio AL, Gállego Pérez-Larraya J, Espinós J, Idoate MA, Domínguez PD, de Eulate RG, Aristu J, Bendandi M, Pastor F, Alonso M, Andreu E, Cardoso FP, Valle RD. Inogés S, et al. J Transl Med. 2017 May 12;15(1):104. doi: 10.1186/s12967-017-1202-z. J Transl Med. 2017. PMID: 28499389 Free PMC article. Clinical Trial.
Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy.
López-Díaz de Cerio A, Perez-Estenaga I, Inoges S, Abizanda G, Gavira JJ, Larequi E, Andreu E, Rodriguez S, Gil AG, Crisostomo V, Sanchez-Margallo FM, Bermejo J, Jauregui B, Quintana L, Fernández-Avilés F, Pelacho B, Prósper F. López-Díaz de Cerio A, et al. Among authors: inoges s. Pharmaceutics. 2021 Aug 17;13(8):1269. doi: 10.3390/pharmaceutics13081269. Pharmaceutics. 2021. PMID: 34452230 Free PMC article.
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.
Bendandi M, Rodríguez-Calvillo M, Inogés S, López-Díaz de Cerio A, Pérez-Simón JA, Rodríguez-Caballero A, García-Montero A, Almeida J, Zabalegui N, Giraldo P, San Miguel J, Orfao A. Bendandi M, et al. Among authors: inoges s. Leuk Lymphoma. 2006 Jan;47(1):29-37. doi: 10.1080/10428190500272473. Leuk Lymphoma. 2006. PMID: 16321824 Clinical Trial.
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S, Inoges S, Lopez-Diaz de Cerio A, Palacios R, Sepulcre J, Moreno B, Gonzalez Z, Fernandez-Diez B, Melero I, Bendandi M, Villoslada P. Martinez-Forero I, et al. Among authors: inoges s. Eur J Immunol. 2008 Feb;38(2):576-86. doi: 10.1002/eji.200737271. Eur J Immunol. 2008. PMID: 18200504 Free article.
71 results